Novo Resources【NVO】銘柄情報

Novo Resources Corp (NVO) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.065

( -1.52% )

買値

0.064

売値

0.067

出来高

47,590

0.064 日の範囲 0.068

0.00 52 週間の範囲 0.00

時価総額

28.119M

前日終値

0.066

始値

0.066

時刻

7000

0.065

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

AUD 232,897

発行済株式数

432,602,519

配当利回り

PER

-1.15

1 株当たり利益 (EPS)

-0.06

歳入

純利益

-21.45M

Novo Resources Corp., together with its subsidiaries, evaluates, acquires, explores, and develops mineral properties in Australia. The company explores for gold and copper deposits. Its flagship project is the Becher Project which covers an area of approximately 20 square kilometers located in the n... Novo Resources Corp., together with its subsidiaries, evaluates, acquires, explores, and develops mineral properties in Australia. The company explores for gold and copper deposits. Its flagship project is the Becher Project which covers an area of approximately 20 square kilometers located in the northern sector of Egina Gold Camp, Western Australia. The company was formerly known as Galliard Resources Corp. and changed its name to Novo Resources Corp. in June 2011. Novo Resources Corp. was incorporated in 2009 and is headquartered in West Perth, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

novoresources.com

本社

West Perth, Australia

設立

2026

Novo Resources Corp is listed in the Materials sector of the オーストラリア証券取引所 with ticker NVO. The last closing price for Novo Resources was AUD0.07. Over the last year, Novo Resources shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Novo Resources currently has 432,602,519 shares in issue. The market capitalisation of Novo Resources is AUD28.12 million. Novo Resources has a price to earnings ratio (PE ratio) of -1.15.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

NVO - Frequently Asked Questions (FAQ)

What is the current Novo Resources Corp share price?

The current share price of Novo Resources Corp is AUD 0.065

How many Novo Resources Corp shares are in issue?

Novo Resources Corp has 432,602,519 shares in issue

What is the market cap of Novo Resources Corp?

The market capitalisation of Novo Resources Corp is AUD 28.12M

What is the 1 year trading range for Novo Resources Corp share price?

Novo Resources Corp has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Novo Resources Corp?

The price to earnings ratio of Novo Resources Corp is -1.15

What is the registered address of Novo Resources Corp?

The registered address for Novo Resources Corp is 46 Ventnor Avenue, West Perth, Western Australia, 6005

What is the Novo Resources Corp website address?

The website address for Novo Resources Corp is novoresources.com

Which industry sector does Novo Resources Corp operate in?

Novo Resources Corp operates in the Mining sector

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Novo Resources Corp (NVO)

Novo Resources Corp (NVO) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

Novo Resources Corp について

NVO 最新ニュース

Novo Nordisk Makes Victoza(R) Commercially Available in the United States

Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

/K I L L K I L L K I L L - National Changing Diabetes Program/

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

Novo Nordisk is Changing Possibilities in Hemophilia

NVO - Frequently Asked Questions (FAQ)

NVO 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Novo Resources Corp (NVO)

Novo Resources Corp (NVO) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

Novo Resources Corp について

NVO 最新ニュース

Novo Nordisk Makes Victoza(R) Commercially Available in the United States

Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

/K I L L K I L L K I L L - National Changing Diabetes Program/

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

Novo Nordisk is Changing Possibilities in Hemophilia

NVO - Frequently Asked Questions (FAQ)

NVO 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

ADVFNに参加する理由

プロトレーダー向けの高機能ツール

広告を削除する

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR